Research On Financial Risk Evaluation And Control Strategy Of XHZY Company

The pharmaceutical industry is an important part of the national economy.China is the most populous country in the world,the pharmaceutical industry is in strong demand and the industry is developing rapidly.With the intensive introduction of new medical reform policies,major changes have taken place,and the financial risks of pharmaceutical manufacturing enterprises have greatly increased.Financial risk management is very important to the business development of an enterprise.If enterprises want to develop healthily and continuously,it needs to build a financial risk evaluation model suitable for the enterprise itself,and scientifically analyze the hidden risks of the enterprise,which will be of great significance to the sustainable development of enterprises.The enterprise studied in this paper is XHZY company,a large state-owned pharmaceutical enterprise in China.Firstly,the paper expounds the relevant theories of financial risk and forms an overall understanding of the financial risk theory.Then,based on the financial statements of XHZY company from 2016 to 2020,combined with the actual situation of the enterprise,the paper uses the financial index analysis method to identify the overall financial risk of the enterprise.In the process of risk identification,it is found that XHZY company has different degrees of potential risks in four aspects of financial risks: financing,investment,operation and growth,among which the occurrence probability of investment risk is the largest.Then,the paper constructs the financial risk evaluation system,determines the specific evaluation indicators by using entropy method and correlation analysis,calculates the score of specific evaluation indicators through the improved efficacy coefficient method,and obtains the financial risk evaluation results from2016 to 2020.It can be seen from the results that the financial risk result in 2016 is medium,and the financial risk result from 2017 to 2020 is good.The investment risk has the greatest impact on the operation and development of company,followed by growth risk,financing risk and operation risk.There are some problems,such as the lack of stable investment and innovation ability of new drugs,and the instability of the formation of new drug research and development.Finally,combined with the results of the company’s financial risk evaluation and analysis,this paper puts forward strategic suggestions to strengthen the financial risk control of XHZY company from the four aspects,hoping to provide some reference for the financial risk early warning of XHZY company.